SNAI2 and pachyonychia congenita: Therefore, SNAI2 expression is correlated with the immunosuppressive tumor immune microenvironment in different manners in primary and metastatic PC, which supports the distinct clinical relevance of SNAI2 expression at different stages of the disease.